Report Detail
Global (United States, European Union and China) Vasculitis Treatment Market Research Report 2019-2025
- RnM3704515 |
- 28 August, 2019 |
- Global |
- 127 Pages |
- QYResearch |
- Other
Vasculitis is a general term that refers to inflammation of blood vessels. When blood vessels become inflamed, they may become weakened, stretch, and either increase in size or become narrow -- even to the point of closing entirely. Vasculitis can affect people of all ages, but there are types of vasculitis that occur in certain age groups more often than others.
The market for vasculitis across the globe is expected to propel significantly during the forecast period. The factors driving the vasculitis market are rising incidences of metabolic disorders and circulatory diseases such as peripheral arterial disease (PAD) and high demand for minimally invasive procedures. In addition, the rising healthcare expenditure and R&D vasculitis treatment and supportive reimbursement policies are estimated to impact the market positively during the forecast period.
In 2019, the market size of Vasculitis Treatment is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Vasculitis Treatment.
This report studies the global market size of Vasculitis Treatment, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Vasculitis Treatment production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbvie
Ablynx
Amgen
Anthera Pharmaceuticals
Aspen Pharmacare Holdings
Astrazeneca
Baxter
Biogen
Bristol-Myers Squibb
Celgene
Celltrion
Chemocentryx
Chugai Pharma Usa
Eisai
Eli Lilly
F. Hoffmann-La Roche
Genentech
Gilead
Glaxosmithkline
Human Genome Sciences
Market Segment by Product Type
Large Vessels
Medium Vessels
Small Vessels
Market Segment by Application
Hospitals And Clinics
Diagnosis Center
Research Institutes
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Vasculitis Treatment status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Vasculitis Treatment manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Vasculitis Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Vasculitis Treatment Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Large Vessels
- 1.3.3 Medium Vessels
- 1.3.4 Small Vessels
- 1.4 Market Segment by Application
- 1.4.1 Global Vasculitis Treatment Market Share by Application (2019-2025)
- 1.4.2 Hospitals And Clinics
- 1.4.3 Diagnosis Center
- 1.4.4 Research Institutes
- 1.4.5 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Vasculitis Treatment Production Value 2014-2025
- 2.1.2 Global Vasculitis Treatment Production 2014-2025
- 2.1.3 Global Vasculitis Treatment Capacity 2014-2025
- 2.1.4 Global Vasculitis Treatment Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Vasculitis Treatment Market Size CAGR of Key Regions
- 2.2.2 Global Vasculitis Treatment Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Vasculitis Treatment Capacity by Manufacturers
- 3.1.2 Global Vasculitis Treatment Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Vasculitis Treatment Revenue by Manufacturers (2014-2019)
- 3.2.2 Vasculitis Treatment Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Vasculitis Treatment Market Concentration Ratio (CR5 and HHI)
- 3.3 Vasculitis Treatment Price by Manufacturers
- 3.4 Key Manufacturers Vasculitis Treatment Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Vasculitis Treatment Market
- 3.6 Key Manufacturers Vasculitis Treatment Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Large Vessels Production and Production Value (2014-2019)
- 4.1.2 Medium Vessels Production and Production Value (2014-2019)
- 4.1.3 Small Vessels Production and Production Value (2014-2019)
- 4.2 Global Vasculitis Treatment Production Market Share by Type
- 4.3 Global Vasculitis Treatment Production Value Market Share by Type
- 4.4 Vasculitis Treatment Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Vasculitis Treatment Consumption by Application
6 Production by Regions
- 6.1 Global Vasculitis Treatment Production (History Data) by Regions 2014-2019
- 6.2 Global Vasculitis Treatment Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Vasculitis Treatment Production Growth Rate 2014-2019
- 6.3.2 United States Vasculitis Treatment Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Vasculitis Treatment Import & Export
- 6.4 European Union
- 6.4.1 European Union Vasculitis Treatment Production Growth Rate 2014-2019
- 6.4.2 European Union Vasculitis Treatment Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Vasculitis Treatment Import & Export
- 6.5 China
- 6.5.1 China Vasculitis Treatment Production Growth Rate 2014-2019
- 6.5.2 China Vasculitis Treatment Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Vasculitis Treatment Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Vasculitis Treatment Consumption by Regions
- 7.1 Global Vasculitis Treatment Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Vasculitis Treatment Consumption by Type
- 7.2.2 United States Vasculitis Treatment Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Vasculitis Treatment Consumption by Type
- 7.3.2 European Union Vasculitis Treatment Consumption by Application
- 7.4 China
- 7.4.1 China Vasculitis Treatment Consumption by Type
- 7.4.2 China Vasculitis Treatment Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Vasculitis Treatment Consumption by Type
- 7.5.2 Rest of World Vasculitis Treatment Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Abbvie
- 8.1.1 Abbvie Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Vasculitis Treatment
- 8.1.4 Vasculitis Treatment Product Introduction
- 8.1.5 Abbvie Recent Development
- 8.2 Ablynx
- 8.2.1 Ablynx Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Vasculitis Treatment
- 8.2.4 Vasculitis Treatment Product Introduction
- 8.2.5 Ablynx Recent Development
- 8.3 Amgen
- 8.3.1 Amgen Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Vasculitis Treatment
- 8.3.4 Vasculitis Treatment Product Introduction
- 8.3.5 Amgen Recent Development
- 8.4 Anthera Pharmaceuticals
- 8.4.1 Anthera Pharmaceuticals Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Vasculitis Treatment
- 8.4.4 Vasculitis Treatment Product Introduction
- 8.4.5 Anthera Pharmaceuticals Recent Development
- 8.5 Aspen Pharmacare Holdings
- 8.5.1 Aspen Pharmacare Holdings Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Vasculitis Treatment
- 8.5.4 Vasculitis Treatment Product Introduction
- 8.5.5 Aspen Pharmacare Holdings Recent Development
- 8.6 Astrazeneca
- 8.6.1 Astrazeneca Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Vasculitis Treatment
- 8.6.4 Vasculitis Treatment Product Introduction
- 8.6.5 Astrazeneca Recent Development
- 8.7 Baxter
- 8.7.1 Baxter Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Vasculitis Treatment
- 8.7.4 Vasculitis Treatment Product Introduction
- 8.7.5 Baxter Recent Development
- 8.8 Biogen
- 8.8.1 Biogen Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Vasculitis Treatment
- 8.8.4 Vasculitis Treatment Product Introduction
- 8.8.5 Biogen Recent Development
- 8.9 Bristol-Myers Squibb
- 8.9.1 Bristol-Myers Squibb Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Vasculitis Treatment
- 8.9.4 Vasculitis Treatment Product Introduction
- 8.9.5 Bristol-Myers Squibb Recent Development
- 8.10 Celgene
- 8.10.1 Celgene Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Vasculitis Treatment
- 8.10.4 Vasculitis Treatment Product Introduction
- 8.10.5 Celgene Recent Development
- 8.11 Celltrion
- 8.12 Chemocentryx
- 8.13 Chugai Pharma Usa
- 8.14 Eisai
- 8.15 Eli Lilly
- 8.16 F. Hoffmann-La Roche
- 8.17 Genentech
- 8.18 Gilead
- 8.19 Glaxosmithkline
- 8.20 Human Genome Sciences
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Vasculitis Treatment Capacity, Production Forecast 2019-2025
- 9.1.2 Global Vasculitis Treatment Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Vasculitis Treatment Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Vasculitis Treatment Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Vasculitis Treatment Production Forecast by Type
- 9.7.2 Global Vasculitis Treatment Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Vasculitis Treatment Sales Channels
- 10.2.2 Vasculitis Treatment Distributors
- 10.3 Vasculitis Treatment Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Vasculitis Treatment. Industry analysis & Market Report on Vasculitis Treatment is a syndicated market report, published as Global (United States, European Union and China) Vasculitis Treatment Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Vasculitis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
